Birchview Capital’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Hold
0
61
2022
Q2
Sell
-20,000
Closed -$14K 61
2022
Q1
$14K Sell
20,000
-80,000
-80% -$56K 0.01% 63
2021
Q4
$226K Hold
100,000
0.15% 60
2021
Q3
$288K Hold
100,000
0.2% 53
2021
Q2
$379K Buy
+100,000
New +$379K 0.23% 50